View in EDS

YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.

Saved in:
Bibliographic Details
Title: YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
Authors: Ma S; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Sun B; College of Life Sciences, Nankai University, Tianjin, China., Duan S; College of Food Science, Sichuan Agricultural University, Ya'an, China., Han J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Barr T; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA., Zhang J; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Los Angeles, CA, USA., Bissonnette MB; Department of Medicine, The University of Chicago, Chicago, IL, USA., Kortylewski M; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA., He C; Departments of Chemistry and Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA., Chen J; Department of Systems Biology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA., Caligiuri MA; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. mcaligiuri@coh.org., Yu J; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA. jiayu@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. jiayu@coh.org.
Source: Nature immunology [Nat Immunol] 2023 Feb; Vol. 24 (2), pp. 255-266. Date of Electronic Publication: 2023 Jan 19.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36658237
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8<superscript>+</superscript> T cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ma+S%22">Ma S</searchLink>; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+B%22">Sun B</searchLink>; College of Life Sciences, Nankai University, Tianjin, China.<br /><searchLink fieldCode="AU" term="%22Duan+S%22">Duan S</searchLink>; College of Food Science, Sichuan Agricultural University, Ya'an, China.<br /><searchLink fieldCode="AU" term="%22Han+J%22">Han J</searchLink>; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Barr+T%22">Barr T</searchLink>; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bissonnette+MB%22">Bissonnette MB</searchLink>; Department of Medicine, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Kortylewski+M%22">Kortylewski M</searchLink>; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22He+C%22">He C</searchLink>; Departments of Chemistry and Biochemistry and Molecular Biology, Institute for Biophysical Dynamics, The University of Chicago, Chicago, IL, USA.; Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Department of Systems Biology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Caligiuri+MA%22">Caligiuri MA</searchLink>; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. mcaligiuri@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. mcaligiuri@coh.org.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Hematologic Malignancies Research Institute, City of Hope National Medical Center, Los Angeles, CA, USA. jiayu@coh.org.; Department of Immuno-Oncology, Beckman Research Institute, City of Hope, Los Angeles, CA, USA. jiayu@coh.org.; Comprehensive Cancer Center, City of Hope, Los Angeles, CA, USA. jiayu@coh.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2023 Feb; Vol. 24 (2), pp. 255-266. <i>Date of Electronic Publication: </i>2023 Jan 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36658237
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41590-022-01398-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 255
    Titles:
      – TitleFull: YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ma S
      – PersonEntity:
          Name:
            NameFull: Sun B
      – PersonEntity:
          Name:
            NameFull: Duan S
      – PersonEntity:
          Name:
            NameFull: Han J
      – PersonEntity:
          Name:
            NameFull: Barr T
      – PersonEntity:
          Name:
            NameFull: Zhang J
      – PersonEntity:
          Name:
            NameFull: Bissonnette MB
      – PersonEntity:
          Name:
            NameFull: Kortylewski M
      – PersonEntity:
          Name:
            NameFull: He C
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Caligiuri MA
      – PersonEntity:
          Name:
            NameFull: Yu J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2023 Feb
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1529-2916
          Numbering:
            – Type: volume
              Value: 24
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Nature immunology
              Type: main
ResultId 1